Jonathan Allan Stoke Therapeutics, Inc. (STOK) insider trading activity
Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. Currently has a direct ownership of 25,631 shares of STOK, which is worth approximately $346,787. The most recent transaction as insider was on Aug 14, 2025, when has been sold 6,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25.6K
18.8%
3M change
886.57%
12M change
Total Value Held
$346,787
Jonathan Allan Transaction History
JA
Jonathan Allan
GENERAL COUNSEL & CORP SEC
Bedford, MA